Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 Apr;38(4):287-342.
doi: 10.1007/s11604-019-00885-5.

Japanese clinical practice guidelines for vascular anomalies 2017

Hidefumi Mimura  1 , Sadanori Akita  2 , Akihiro Fujino  3 , Masatoshi Jinnin  4 , Mine Ozaki  5 , Keigo Osuga  6 , Hiroki Nakaoka  7 , Eiichi Morii  8 , Akira Kuramochi  9 , Yoko Aoki  10 , Yasunori Arai  11 , Noriko Aramaki  12 , Masanori Inoue  13 , Yuki Iwashina  5 , Tadashi Iwanaka  14 , Shigeru Ueno  15 , Akihiro Umezawa  16 , Michio Ozeki  17 , Junko Ochi  18 , Yoshiaki Kinoshita  19 , Masakazu Kurita  20 , Shien Seike  21 , Nobuyuki Takakura  22 , Masataka Takahashi  16 , Takao Tachibana  23 , Kumiko Chuman  24 , Shuji Nagata  25 , Mitsunaga Narushima  26 , Yasunari Niimi  27 , Shunsuke Nosaka  28 , Taiki Nozaki  29 , Kazuki Hashimoto  11 , Ayato Hayashi  30 , Satoshi Hirakawa  31 , Atsuko Fujikawa  11 , Yumiko Hori  8 , Kentaro Matsuoka  32 , Hideki Mori  7 , Yuki Yamamoto  4 , Shunsuke Yuzuriha  33 , Naoaki Rikihisa  34 , Shoji Watanabe  35 , Shinichi Watanabe  36 , Tatsuo Kuroda  37 , Shunsuke Sugawara  38 , Kosuke Ishikawa  39 , Satoru Sasaki  40
Affiliations
Practice Guideline

Japanese clinical practice guidelines for vascular anomalies 2017

Hidefumi Mimura et al. Jpn J Radiol. 2020 Apr.

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

Keywords: Clinical practice; Guidelines; Hemangioma; Vascular anomalies; Vascular malformation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest of the guidelines preparation organization was managed by the Guidelines Executive Committee. The following corporations were disclosed by self-declaration of the Guidelines Committee members in the 3 year-period before 1 April 2017. Japan Pharmaceuticals and Medical Devices Agency (PMDA), Mitsubishi Foundation, Rohto Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Shionogi & Co., Ltd.

Figures

Fig. 1
Fig. 1
Reports of laser therapy for hemangiomas/vascular malformations (primarily venous) in various periods and types of laser used in the reports. CO2; 10 of 11 reports recommend the use for surgical resection. Argon; There are 4 reports of mixed treatments for CM and VM. Nd:YAG; There are 12 reports of its use in combination therapy with surgery, sclerotherapy, or other lasers. Alexandrite; There is only 1 report summarizing cases treated with alexandrite in combination therapy with other lasers
See this image and copyright information in PMC

References

    1. ISSVA Classification of Vascular Anomalies© 2014 International Society for the Study of Vascular Anomalies. http://www.issva.org/classification. Accessed Apr 2014.
    1. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136:e203–e214. doi: 10.1542/peds.2014-3673. - DOI - PubMed
    1. Clinical practice guidelines for vascular anomalies. The Research Committee of Intractable Vascular Anomalies, Research on Measures for Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan. 2013. http://www.marianna-u.ac.jp/va/files/vascular%20anomalies%20practice%20g.... Accessed 29 Mar 2013 (Japanese).
    1. Fukui T, Yamaguchi N, Morizane T, Yoshida M, Kojimahara N (eds). Minds handbook for clinical practice guideline development 2014. Ver 1.0, Tokyo: Minds Guideline Center, Japan Council for Quality Health Care. 2014. http://minds4.jcqhc.or.jp/minds/guideline/pdf/MindsHB2014.pdf. Accessed 1 Feb 2015.
    1. Morizane T, Yoshida M (eds). Minds manual for guideline development Ver. 1.0. Tokyo: Japan Council for Quality Health Care. Accessed 31 Mar 2014 (Japanese).

Publication types